•  
  •  
 

Abstract

Objectives: The purpose of this study was to analyze and evaluate evidence supporting curcumin lowering the systemic inflammatory marker, CRP in humans. Methods: A systematic literature search was completed using PubMed and MEDLINE databases. Results: After inclusion and exclusion criteria, 9 studies were evaluated, and the percent change of CRP blood levels was calculated and analyzed. Results: The results for these studies show strong statistical significance for the C3 complex with Bioperine and nano curcumin. Bioactive curcumin exhibits a higher percent decrease of blood level CRP than trials using only curcumin or turmeric. Conclusion: Overall bioactive curcumin/ curcumin with Bioperine are alternative treatments for lowering the systemic inflammation marker, CRP.

Author Bio(s)

Lauren Katakowski is a Master's student at Central Michigan University, in the program of Nutrition and Dietetics.

Susan Hewlings, Ph.D., RD, is a professor at Central Michigan University for the Nutrition and Dietetics program.

Acknowledgements

Margret Danowski, Health Professions Librarian, Central Michigan University, for her assistance with the literature search.

Share

 
COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.